Cargando…
Multiple Myeloma: An Overview of the Current and Novel Therapeutic Approaches in 2020
SIMPLE SUMMARY: The therapeutics of multiple myeloma (MM) have greatly evolved in recent years both in the first-line setting and at relapse, and for both young and older patients. While still being considered as uncurable, MM survival has significantly increased. The development of immunotherapy (n...
Autores principales: | Bobin, Arthur, Liuu, Evelyne, Moya, Niels, Gruchet, Cécile, Sabirou, Florence, Lévy, Anthony, Gardeney, Hélène, Nsiala, Laly, Cailly, Laura, Guidez, Stéphanie, Tomowiak, Cécile, Systchenko, Thomas, Javaugue, Vincent, Durand, Géraldine, Leleu, Xavier, Puyade, Mathieu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600346/ https://www.ncbi.nlm.nih.gov/pubmed/33050025 http://dx.doi.org/10.3390/cancers12102885 |
Ejemplares similares
-
The Role of Immunotherapy in Non-transplant Eligible Multiple Myeloma
por: Bobin, Arthur, et al.
Publicado: (2020) -
Novel Non-Immunologic Agents for Relapsed and Refractory Multiple Myeloma: A Review Article
por: Bobin, Arthur, et al.
Publicado: (2021) -
Three Drug Combinations in the Treatment of Fit Elderly Multiple Myeloma Patients
por: Gardeney, Hélène, et al.
Publicado: (2020) -
Hairy cell leukemia with isolated bone lesions
por: Cailly, Laura, et al.
Publicado: (2023) -
Hodgkin lymphoma and female fertility: a multicenter study in women treated with doxorubicin, bleomycin, vinblastine, and dacarbazine
por: Machet, Antoine, et al.
Publicado: (2022)